NAPA Reauthorization Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (May 12, 2022)
NAPA Reauthorization Act
This bill extends through 2035 and makes other changes to the National Alzheimer's Project. This project supports coordination of federal planning, programs, and other efforts to address Alzheimer's disease and related dementias.
In particular, the bill incorporates a focus on promoting healthy aging and reducing risk factors associated with cognitive decline.
The bill also expands the membership of the Advisory Council on Alzheimer's Research, Care, and Services to include (1) a researcher with experience recruiting and retaining diverse clinical trial participants, (2) an individual diagnosed with Alzheimer's disease, and (3) representatives from additional federal agencies (e.g., the Department of Justice and the Office of Management and Budget).
What just happenedMay 12, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2494-2495)
Who’s behind it
- Introduced in SenateMay 12, 2022
- May 12, 2022IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2494-2495)
Health, Education, Labor, and Pensions Committee - May 12, 2022IntroReferral10000
Introduced in Senate